Bronnen: wij volgen de wijzigingen op basis van informatie van het College ter Beoordeling van Geneesmiddelen (CBG) — de Geneesmiddeleninformatiebank (inschrijvingen en doorgehaalde handelsvergunningen, dagelijks vergeleken) en DHPC-brieven — en van de Inspectie Gezondheidszorg en Jeugd (terugroepacties). Besluiten over centraal toegelaten geneesmiddelen komen uit het Uniebestand van de Europese Commissie (EU-label). Voor tekorten en vergoedingen bestaan in Nederland geen open overheidsgegevens; die staan hier (nog) niet. Alternatieven met dezelfde werkzame stof: database van Lekoskop.
nr. EU/1/26/2062 · Zokovea is indicated for the post exposure prophylaxis of COVID 19 in adults and adolescents aged 12 years and… · Shionogi B.V. · ensitrelvir · ATC J05AE16
nr. EU/1/26/2055 · Ubeslo is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or m… · A. Menarini International Licensing S.A. · Obicetrapib · ATC C10AX
nr. EU/1/26/2065 · Tafamidis Accord is indicated for the treatment of hereditary transthyretin amyloidosis in adult patients with… · Accord Healthcare S.L.U. · tafamidis · ATC N07XX08
nr. EU/1/26/2064 · Myelofibrosis (MF)
Ruxolitinib Viatris is indicated for the treatment of disease-related splenomegaly or … · Viatris Limited · ruxolitinib · ATC L01EJ01
nr. EU/1/26/2056 · Evlarco is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or … · A. Menarini International Licensing S.A. · obicetrapib / ezetimibe
nr. EU/1/25/2006 · toegelaten op 12-02-2026 · Aumseqa as monotherapy is indicated for:
• the first line treatment of adult patients with advanced non small… · SFL Pharmaceuticals Deutschland GmbH · aumolertinib · ATC L01EB11
nr. EU/1/21/1608 · toegelaten op 06-01-2022 · Adults
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for wei… · Novo Nordisk A/S · semaglutide · ATC A10BJ06
nr. EU/1/23/1770 · toegelaten op 07-12-2023 · ELREXFIO is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple… · Pfizer Europe MA EEIG · elranatamab · ATC L01FX32
nr. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
nr. EU/1/26/2061 · LYROKAUL is indicated in adults with primary hypercholesterolaemia (heterozygous familial (HeFH) and non-famil… · LIB Therapeutics B.V. · Lerodalcibep · ATC C10AX19
nr. EU/1/23/1751 · toegelaten op 15-09-2023 · Yesafili is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (… · Biosimilar Collaborations Ireland Limited · aflibercept · ATC S01LA05
nr. EU/1/23/1758 · toegelaten op 15-09-2023 · Non-small cell lung cancer (NSCLC)
Tevimbra, in combination with platinum-containing chemotherapy as neoadj… · BeOne Medicines Ireland Limited · tislelizumab · ATC L01FF09
nr. EU/1/20/1498 · toegelaten op 09-12-2020 · Trixeo Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic ob… · AstraZeneca AB · Formoterol / glycopyrronium bromide / budesonide · ATC R03AL11
nr. EU/1/21/1588 · toegelaten op 12-11-2021 · Rivaroxaban Viatris co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticl… · Viatris Limited · rivaroxaban · ATC B01AF01
nr. EU/1/21/1604 · toegelaten op 06-01-2022 · Riltrava Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic … · AstraZeneca AB · formoterol / glycopyrronium bromide / budesonide · ATC R03AL11
nr. EU/1/01/189 · toegelaten op 03-08-2001 · Replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry… · Takeda Pharmaceuticals International AG Ireland Branch · Agalsidase alfa · ATC A16AB03
nr. EU/1/19/1404 · toegelaten op 16-12-2019 · Rheumatoid arthritis
RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthriti… · AbbVie Deutschland GmbH & Co. KG · upadacitinib · ATC L04AF03
nr. EU/1/25/1909 · toegelaten op 04-04-2025 · Pavblu is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AM… · Amgen Technology (Ireland) UC · Aflibercept · ATC S01LA05
nr. EU/1/24/1863 · toegelaten op 25-09-2024 · Adult Crohn’s disease
Otulfi is indicated for the treatment of adult patients with moderately to severely act… · Fresenius Kabi Deutschland GmbH · ustekinumab · ATC L04AC05
nr. EU/1/24/1865 · toegelaten op 13-11-2024 · Opuviz is indicated for adults for the treatment of
• neovascular (wet) age related macular degeneration (AMD… · Samsung Bioepis NL B.V. · Aflibercept · ATC S01LA05
nr. EU/1/18/1277 · toegelaten op 19-04-2018 · MYLOTARG is indicated for combination therapy with daunorubicin (DNR) and cytarabine (AraC) for the treatment … · Pfizer Europe MA EEIG · gemtuzumab ozogamicin · ATC L01FX02
nr. EU/1/22/1649 · toegelaten op 03-06-2022 · Lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicula… · Roche Registration GmbH · mosunetuzumab · ATC L01FX25
nr. EU/1/23/1755 · toegelaten op 15-09-2023 · Litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and… · Pfizer Europe MA EEIG · ritlecitinib · ATC L01EJ
nr. EU/1/19/1356 · toegelaten op 02-04-2019 · Rheumatoid arthritis
Idacio in combination with methotrexate, is indicated for:
the treatment of moderate… · Fresenius Kabi Deutschland GmbH · adalimumab · ATC L04AB04
nr. EU/1/24/1802 · toegelaten op 17-05-2024 · Paroxysmal nocturnal haemoglobinuria
FABHALTA is indicated as monotherapy in the treatment of adult patients … · Novartis Europharm Limited · iptacopan · ATC L04AJ08
nr. EU/1/12/797 · toegelaten op 22-11-2012 · Eylea 40 mg/mL :
Eylea is indicated for adults for the treatment of
• neovascular (wet) age-related macul… · Bayer AG · aflibercept · ATC S01LA05
nr. EU/1/25/1963 · toegelaten op 14-08-2025 · Eiyzey is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AMD… · Zakłady Farmaceutyczne POLPHARMA S.A. · aflibercept · ATC S01LA05
nr. EU/1/15/1047 · toegelaten op 23-11-2015 · BLINCYTO is indicated as monotherapy for the treatment of adults with CD19 positive relapsed or refractory B c… · Amgen Europe B.V. · blinatumomab · ATC L01FX07
nr. EU/1/24/1888 · toegelaten op 13-01-2025 · Ahzantive is indicated for adults for the treatment of:
• neovascular (wet) age-related macular degeneration … · Formycon AG · Aflibercept · ATC S01LA05
nr. EU/1/24/1844 · toegelaten op 22-08-2024 · Adult Crohn’s Disease
Steqeyma is indicated for the treatment of adult patients with moderately to severely a… · Celltrion Healthcare Hungary Kft. · ustekinumab · ATC L04AC05
nr. EU/1/08/461 · toegelaten op 11-07-2008 · Firazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adol… · Takeda Pharmaceuticals International AG Ireland Branch · icatibant · ATC B06AC02
Lekoskop